October 20, 2025 at 9:50 PM
Is #IDweek Community Leaving X?
Not yet! After digging into both #IDWeek2023 and #IDWeek2024 tweets data, and crunching some numbers to compare user activity, it’s clear we haven’t lost our spark.
www.kenkoonwong.com/blog/idweek_...
Not yet! After digging into both #IDWeek2023 and #IDWeek2024 tweets data, and crunching some numbers to compare user activity, it’s clear we haven’t lost our spark.
www.kenkoonwong.com/blog/idweek_...
Is #IDWeek Community Leaving X? | Everyday Is A School Day
Not yet! After digging into both #IDWeek2023 and #IDWeek2024 tweets data, and crunching some numbers to compare user activity, it's clear we haven't lost our spark. Our ID community is still here, sha...
www.kenkoonwong.com
October 27, 2024 at 4:12 AM
Is #IDweek Community Leaving X?
Not yet! After digging into both #IDWeek2023 and #IDWeek2024 tweets data, and crunching some numbers to compare user activity, it’s clear we haven’t lost our spark.
www.kenkoonwong.com/blog/idweek_...
Not yet! After digging into both #IDWeek2023 and #IDWeek2024 tweets data, and crunching some numbers to compare user activity, it’s clear we haven’t lost our spark.
www.kenkoonwong.com/blog/idweek_...
✔ REMINDER | Webinar TOMORROW | 11/16/23 at 1:00pm EST.
Don't forget to REGISTER 👇 & add it to your calendar! attendee.gotowebinar.com/register/258...
🙋♀️❓🙋♂️ Stay for the Q&A
Topics include but not limited to:
· CMV, HIV, & hepatitis-C in transplantation & Covid-19
#idweek2023 #ganciclovir #CMV
Don't forget to REGISTER 👇 & add it to your calendar! attendee.gotowebinar.com/register/258...
🙋♀️❓🙋♂️ Stay for the Q&A
Topics include but not limited to:
· CMV, HIV, & hepatitis-C in transplantation & Covid-19
#idweek2023 #ganciclovir #CMV
November 15, 2023 at 5:30 PM
✔ REMINDER | Webinar TOMORROW | 11/16/23 at 1:00pm EST.
Don't forget to REGISTER 👇 & add it to your calendar! attendee.gotowebinar.com/register/258...
🙋♀️❓🙋♂️ Stay for the Q&A
Topics include but not limited to:
· CMV, HIV, & hepatitis-C in transplantation & Covid-19
#idweek2023 #ganciclovir #CMV
Don't forget to REGISTER 👇 & add it to your calendar! attendee.gotowebinar.com/register/258...
🙋♀️❓🙋♂️ Stay for the Q&A
Topics include but not limited to:
· CMV, HIV, & hepatitis-C in transplantation & Covid-19
#idweek2023 #ganciclovir #CMV
News from #IDWeek2023 & #EACS2023: #HIV+ people treated with trichloroacetic acid were about as likely to experience improvement of precancerous anal cell lesions as those who underwent electrocautery, but were less likely to experience side effects. 1/
Screening and Early Treatment for Anal Cancer in People With HIV
Topical treatment may be as effective as electrocautery for anal neoplasia but with fewer adverse effects.
www.poz.com
October 22, 2023 at 10:05 PM
News from #IDWeek2023 & #EACS2023: #HIV+ people treated with trichloroacetic acid were about as likely to experience improvement of precancerous anal cell lesions as those who underwent electrocautery, but were less likely to experience side effects. 1/
News from #IDWeek2023: After rising for over a decade, new cases of liver cancer began to decline among people with #hepatitisC in NYC after the advent of effective antiviral treatment. But many people are not aware they carry HCV & only a third have been successfully treated.
Liver Cancer Declined After Advent of Hepatitis C Treatment
Hepatocellular carcinoma among people with HCV fell after the debut of direct-acting antivirals, but cases are rising for other groups.
www.hepmag.com
October 19, 2023 at 1:56 AM
News from #IDWeek2023: After rising for over a decade, new cases of liver cancer began to decline among people with #hepatitisC in NYC after the advent of effective antiviral treatment. But many people are not aware they carry HCV & only a third have been successfully treated.
News from #IDWeek2023 & #EACS2023: Sunlenca (lenacapavir) remains active at 2 years in people with resistant #HIV, mostly mild to moderate injection site reactions, proportion with CD4 count <200 fell from 64% at baseline to 29%.
Sunlenca Remains Active Against Drug-Resistant HIV
After two years on lenacapavir, people with advanced immune suppression experienced substantial gains in CD4 T cells.
www.poz.com
October 18, 2023 at 7:36 PM
News from #IDWeek2023 & #EACS2023: Sunlenca (lenacapavir) remains active at 2 years in people with resistant #HIV, mostly mild to moderate injection site reactions, proportion with CD4 count <200 fell from 64% at baseline to 29%.
A gift to myself while at #IDWeek2023
Motivated for work, patient care, research & running after getting back from Boston
The TC Marathon was canceled the morning of on 10/1. Maybe 1 day I can cross the finish on #Boylston
#IDSky
#RunTheSky
Motivated for work, patient care, research & running after getting back from Boston
The TC Marathon was canceled the morning of on 10/1. Maybe 1 day I can cross the finish on #Boylston
#IDSky
#RunTheSky
October 18, 2023 at 2:55 AM
A gift to myself while at #IDWeek2023
Motivated for work, patient care, research & running after getting back from Boston
The TC Marathon was canceled the morning of on 10/1. Maybe 1 day I can cross the finish on #Boylston
#IDSky
#RunTheSky
Motivated for work, patient care, research & running after getting back from Boston
The TC Marathon was canceled the morning of on 10/1. Maybe 1 day I can cross the finish on #Boylston
#IDSky
#RunTheSky
First and foremost, #IDWeek2023 was amazing & ID docs are the best!
Missing all you amazing folks out there! See you in LA!
Missing all you amazing folks out there! See you in LA!
October 17, 2023 at 3:01 AM
First and foremost, #IDWeek2023 was amazing & ID docs are the best!
Missing all you amazing folks out there! See you in LA!
Missing all you amazing folks out there! See you in LA!
News from #IDWeek2023: Having antiretrovirals on hand to take after infrequent exposures—an approach dubbed PEP-in-pocket, or PIP—is a feasible #HIV prevention option.
PEP-in-Pocket Is Another Option for HIV Prevention
Providing a course of antiretrovirals to use after infrequent HIV exposures could lower cost and remove barriers to access.
www.poz.com
October 17, 2023 at 1:21 AM
News from #IDWeek2023: Having antiretrovirals on hand to take after infrequent exposures—an approach dubbed PEP-in-pocket, or PIP—is a feasible #HIV prevention option.
Das Coronavirus infiziert den männlichen Genitaltrakt: Neue Studie zeigt direkte Auswirkungen von COVID-19 auf die männliche Gesundheit www.dmz-news.eu/2023/10/16/d... #Covid #Covid19 #Covid_19 #SARSCoV2 #Corona #CovidIsNotOver #LongCovid #Pandemie #Studie #Impfung #CoviLiv #IDWeek2023 #Impfstoff
Das Coronavirus infiziert den männlichen Genitaltrakt: Neue Studie zeigt direkte Auswirkungen von C...
DMZ – WISSENSCHAFT ¦ Anton Aeberhard ¦ Eine neue Studie der Feinberg School of Medicine an der Northwestern University zeigt, dass verschiedene Gewebe des männlichen Genitaltrakts mit dem SARS-Co...
www.dmz-news.eu
October 15, 2023 at 9:59 AM
Das Coronavirus infiziert den männlichen Genitaltrakt: Neue Studie zeigt direkte Auswirkungen von COVID-19 auf die männliche Gesundheit www.dmz-news.eu/2023/10/16/d... #Covid #Covid19 #Covid_19 #SARSCoV2 #Corona #CovidIsNotOver #LongCovid #Pandemie #Studie #Impfung #CoviLiv #IDWeek2023 #Impfstoff
Die Wirksamkeit von COVID-19-Impfungen bei der Verhinderung von post-COVID-Bedingungen www.dmz-news.eu/2023/10/14/d... #Covid #Covid19 #Covid_19 #SARSCoV2 #Corona #CovidIsNotOver #LongCovid #Pandemie #Studie #Impfung #CoviLiv #IDWeek2023 #Impfstoff
Die Wirksamkeit von COVID-19-Impfungen bei der Verhinderung von post-COVID-Bedingungen
DMZ – FORSCHUNG ¦ Lena Wallner ¦ Eine systematische Literaturübersicht und Meta-Analyse der neuesten Forschung Eine kürzlich durchgeführte systematische Literaturübersicht und Meta-Analyse hat...
www.dmz-news.eu
October 14, 2023 at 7:46 PM
Die Wirksamkeit von COVID-19-Impfungen bei der Verhinderung von post-COVID-Bedingungen www.dmz-news.eu/2023/10/14/d... #Covid #Covid19 #Covid_19 #SARSCoV2 #Corona #CovidIsNotOver #LongCovid #Pandemie #Studie #Impfung #CoviLiv #IDWeek2023 #Impfstoff
Just published online first in JAMA & presented #IDWeek2023
Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical Trial
jamanetwork.com/journals/jam...
Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical Trial
jamanetwork.com/journals/jam...
October 14, 2023 at 7:27 PM
Just published online first in JAMA & presented #IDWeek2023
Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical Trial
jamanetwork.com/journals/jam...
Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical Trial
jamanetwork.com/journals/jam...
Fortschritte in der Erforschung der SARS-CoV-2-Infektionen www.dmz-news.eu/2023/10/14/f... #Covid #Covid19 #Covid_19 #SARSCoV2 #Corona #CovidIsNotOver #LongCovid #Pandemie #Studie #Impfung #CoviLiv #IDWeek2023 #Impfstoff
Fortschritte in der Erforschung der SARS-CoV-2-Infektionen
DMZ – FORSCHUNG ¦ Lena Wallner ¦ Die kürzlich veröffentlichte Studie "Viral kinetics of sequential SARS-CoV-2 infections" hat uns spannende Erkenntnisse darüber geliefert, wie aufeinanderfolgen...
www.dmz-news.eu
October 14, 2023 at 5:16 PM
Fortschritte in der Erforschung der SARS-CoV-2-Infektionen www.dmz-news.eu/2023/10/14/f... #Covid #Covid19 #Covid_19 #SARSCoV2 #Corona #CovidIsNotOver #LongCovid #Pandemie #Studie #Impfung #CoviLiv #IDWeek2023 #Impfstoff
News from #IDWeek: Experimental intranasal #COVID vaccine targets entire virus rather than just spike protein, which could provide broader protection against viral variants. #IDWeek2023
COVID-19 Intranasal Vaccine Candidate Produces Robust Immune Response
The live-attenuated vaccine aims to produce an immune response to the entire virus rather than the frequently mutating spike protein.
www.covidhealth.com
October 13, 2023 at 9:22 PM
News from #IDWeek: Experimental intranasal #COVID vaccine targets entire virus rather than just spike protein, which could provide broader protection against viral variants. #IDWeek2023
Reminder: Langzeitfolgen von SARS-Überlebenden: 18-jährige Studie liefert Einsichten www.dmz-news.eu/2023/10/14/r... #Covid #Covid19 #Covid_19 #SARSCoV2 #Corona #CovidIsNotOver #LongCovid #Pandemie #Studie #Impfung #CoviLiv #IDWeek2023 #Impfstoff
Reminder: Langzeitfolgen von SARS-Überlebenden: 18-jährige Studie liefert Einsichten
DMZ – WISSENSCHAFT ¦ Sarah Koller ¦ In den letzten zwei Jahrzehnten haben Coronaviren (CoVs) mehrere Pandemien verursacht, darunter das schwere akute Atemwegssyndrom (SARS), das Middle East Respir...
www.dmz-news.eu
October 13, 2023 at 6:30 PM
Reminder: Langzeitfolgen von SARS-Überlebenden: 18-jährige Studie liefert Einsichten www.dmz-news.eu/2023/10/14/r... #Covid #Covid19 #Covid_19 #SARSCoV2 #Corona #CovidIsNotOver #LongCovid #Pandemie #Studie #Impfung #CoviLiv #IDWeek2023 #Impfstoff
Codagenix präsentiert auf IDWeek 2023 ermutigende klinische Daten für COVID-19-Impfstoffkandidaten CoviLiv www.dmz-news.eu/2023/10/13/c... #Covid #Covid19 #Covid_19 #SARSCoV2 #Corona #CovidIsNotOver #LongCovid #Pandemie #Studie #Impfung #CoviLiv #IDWeek2023 #Impfstoff
Codagenix präsentiert auf IDWeek 2023 ermutigende klinische Daten für COVID-19-Impfstoffkandidaten...
DMZ – FORSCHUNG ¦ Lena Wallner ¦ Codagenix Inc., ein biotechnologisches Unternehmen im klinischen Stadium mit einer innovativen Plattform für die Gestaltung viraler Impfstoffe und Therapeutika in...
www.dmz-news.eu
October 13, 2023 at 7:20 AM
Codagenix präsentiert auf IDWeek 2023 ermutigende klinische Daten für COVID-19-Impfstoffkandidaten CoviLiv www.dmz-news.eu/2023/10/13/c... #Covid #Covid19 #Covid_19 #SARSCoV2 #Corona #CovidIsNotOver #LongCovid #Pandemie #Studie #Impfung #CoviLiv #IDWeek2023 #Impfstoff
IDWeek 2023 Photo Gallery
IDWeek 2023 Photo Gallery
kellipricephotography.shootproof.com
October 12, 2023 at 3:21 PM
3 bhattacharyyalab.org posters today @ #IDWeek2023!
#250 PierreAnkomah: kinetics of a novel monocyte subtype in sepsis, implications for immunopathology
#623 Eleanor Young: a promising approach to fungal diagnostics
#875 David Roach: democratizing AMR diagnostics
Stop by!
#250 PierreAnkomah: kinetics of a novel monocyte subtype in sepsis, implications for immunopathology
#623 Eleanor Young: a promising approach to fungal diagnostics
#875 David Roach: democratizing AMR diagnostics
Stop by!
October 12, 2023 at 1:13 PM
3 bhattacharyyalab.org posters today @ #IDWeek2023!
#250 PierreAnkomah: kinetics of a novel monocyte subtype in sepsis, implications for immunopathology
#623 Eleanor Young: a promising approach to fungal diagnostics
#875 David Roach: democratizing AMR diagnostics
Stop by!
#250 PierreAnkomah: kinetics of a novel monocyte subtype in sepsis, implications for immunopathology
#623 Eleanor Young: a promising approach to fungal diagnostics
#875 David Roach: democratizing AMR diagnostics
Stop by!
Grant application submitted. Now off to Boston for #IDWeek2023
October 11, 2023 at 6:21 PM
Grant application submitted. Now off to Boston for #IDWeek2023